SOUTH SAN FRANCISCO, Calif., March 11, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, will announce its 2007 fourth quarter and year-end results on Tuesday, March 25, 2008, after the close of the financial markets.
Following the announcement, Hana Biosciences' management team will host a conference call to include a discussion of earnings and a business update at 5:00pm EDT, 2:00pm PDT. Participants may join the call by dialing (877) 407-8031 in the U.S./Canada. International participants may access the call by dialing (201) 689-8031. Those interested in hearing management's discussion may also access a live webcast of the conference call on Hana's website at www.hanabiosciences.com.
A replay of this call will be available for one month by dialing (877) 660-6853 U.S./Canada and (201) 612-7415 for International participants. When prompted, enter Account Number #286 and Conference ID #278502. The webcast will also be available via the company's website.
About Hana Biosciences, Inc.
Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture. Additional information on Hana Biosciences can be found at www.hanabiosciences.com.
The Hana Biosciences, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3290